LWP
CNCR
Legacy Wealth Partners’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $525K | Sell |
16,464
-4,008
| -20% | -$128K | 0.29% | 66 |
|
|
2021
Q1 | $613K | Buy |
20,472
+5,042
| +33% | +$151K | 0.36% | 59 |
|
|
2020
Q4 | $489K | Buy |
15,430
+6,161
| +66% | +$195K | 0.31% | 59 |
|
|
2020
Q3 | $255K | Sell |
9,269
-620
| -6% | -$17.1K | 0.18% | 80 |
|
|
2020
Q2 | $268K | Buy |
+9,889
| New | +$268K | 0.2% | 83 |
|